Belantamab Mafodotin Combo Shows PFS Improvement in R/R Multiple Myeloma

被引：0
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2024年 / 38卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：44
相关论文
共 50 条
  • [11] The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma
    Arleigh McCurdy
    Alissa Visram
    Current Hematologic Malignancy Reports, 2022, 17 : 306 - 318
  • [12] Belantamab-mafodotin treatment for relapsed or refractory multiple myeloma
    Stocker, Nicolas
    HEMATOLOGIE, 2020, 26 (02): : 99 - 100
  • [13] Corneal Changes After Belantamab Mafodotin in Multiple Myeloma Patients
    Bausell, Rebecca B.
    Soleimani, Arshia
    Vinnett, Alfred
    Baroni, Mariana D.
    Staub, Sheila A.
    Binion, Katrina
    Jeng, Bennie H.
    Badros, Ashraf Z.
    Munir, Wuqaas M.
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2021, 47 (06): : 362 - 365
  • [14] Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over
    Condorelli, Annalisa
    Garibaldi, Bruno
    Gagliano, Caterina
    Romano, Alessandra
    Del Fabro, Vittorio
    Parrinello, Nunziatina Laura
    Longo, Antonio
    Cosentino, Sebastiano
    Di Raimondo, Francesco
    Conticello, Concetta
    ACTA HAEMATOLOGICA, 2024, 147 (04) : 493 - 498
  • [15] Iatrogenic keratopathy secondary to multiple myeloma treatment with belantamab mafodotin
    Menardais, B.
    Soethoudt, M.
    Espargilliere, D.
    Mouriaux, F.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2021, 44 (05): : 766 - 768
  • [16] The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma
    Becnel, Melody R.
    Lee, Hans C.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [17] Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over
    Condorelli, Annalisa
    Garibaldi, Bruno
    Gagliano, Caterina
    Romano, Alessandra
    Del Fabro, Vittorio
    Parrinello, Nunziatina Laura
    Longo, Antonio
    Cosentino, Sebastiano
    Di Raimondo, Francesco
    Conticello, Concetta
    ACTA HAEMATOLOGICA, 2021,
  • [18] FIRST USE EXPERIENCE OF BELANTAMAB MAFODOTIN IN MULTIPLE MYELOMA PATIENTS ON DIALYSIS
    Montesinos Lorena, Martinez
    Maria Magdalena, Anguita Arance
    Alonso Aranzazu, Alonso
    Moreno Maria, Jimenez
    Torres Alejandra, Segado
    de la Fuente Felipe, De Arriba
    HAEMATOLOGICA, 2021, 106 (10) : 138 - 139
  • [19] Adverse ocular events related to belantamab mafodotin for treatment of multiple myeloma
    Lent-Schochet, Daniella
    Mokhashi, Nikita
    Vidyasagar, Nitin
    Farooq, Asim
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [20] Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety
    Offidani, Massimo
    Corvatta, Laura
    More, Sonia
    Olivieri, Attilio
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2401 - 2415
12345